When working with documents under regulatory control, Alfresco and Generis CARA, will significantly lower the overall cost of content management systems and provide a seamless upgrade to the newest cloud enabled technology.
SANTA BARBARA, CALIFORNIA (PRWEB) June 11, 2014
USDM Life Sciences, a leading global regulatory consulting firm in the life sciences industry, is proud to announce Alfresco, Generis and USDM Life Sciences have partnered to offer a next generation Enterprise Content Management solution. The solution is able to meet existing and future life sciences organization needs while significantly lowering the overall cost of content management systems.
The Alfresco content management platform eliminates information silos and provides quick and easy access to the right content from any system or device. With flexible on-premise cloud and hybrid deployment options, Alfresco places the power of content management in the hands of business users and reduces demands on IT departments. Alfresco significantly lowers the cost of software acquisition and ownership.
Generis CARA is an ergonomically designed, fast, web user interface and business rules engine. It is designed to facilitate the creation, review, approval and management of documents for life sciences customers. CARA provides additional functionalities to better manage controlled documents.
USDM Life Sciences:
USDM Life Sciences specializes in helping life sciences companies select and implement best in class IT solutions while achieving and maintaining compliance with FDA regulations. USDM’s ECM and Life Sciences Cloud Solutions and Services are helping life sciences companies move to next generation content management solutions.
“When working with documents under regulatory control, Alfresco and Generis CARA, will significantly lower the overall cost of content management systems and provide a seamless upgrade to the newest cloud enabled technology,” said Gerald O’Driscoll, Vice President of USDM’s ECM Solutions and Services.
“The opportunity to work with USDM and leverage their expertise in life sciences content management implementation and support is of key importance to us,” said James Kelleher, CEO of Generis. USDM will tailor CARA deployments to specific life sciences uses and regulatory requirements.”
Learn more about the next generation Enterprise Content Management solution at the Alfresco booth (#533) during the DIA Annual Meeting. The DIA Annual Meeting is June 15-19, 2014 at the San Diego Convention Center in San Diego, CA.
About USDM Life Sciences:
USDM Life Sciences is a leading global regulatory consulting firm providing compliance, validation, qualification, quality, auditing and information technology services via project teams and staff augmentation to our clients in the medical device, biotechnology, biologics, diagnostics and pharmaceutical industries. For more information, please visit http://www.usdm.com.